Skip to main content
    C

    China Pharma Holdings Inc (CPHI)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • AMEX

    $0.50
    +0.02 (+4.42%)

    Market Cap: $22.29M

    Last updated: Nov 17, 2026 at 4:25 PM ET

    China Pharma Holdings Inc (CPHI) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    China Pharma Holdings (CPHI) has a market cap of $22.29M and an enterprise value of $25.59M. Its share count is up 1156.05% from a year earlier. It kept -114.33% of revenue as net income over the last 12 months.

    Total Valuation

    Enterprise value is 14.80% above the market cap, as debt exceeds cash.

    Market Cap$22.29M
    Enterprise Value$25.59M
    Latest price (Nov 17, 2026)$0.50

    Key Dates

    The next earnings report is expected on Nov 18, 2026, covering the quarter ending Sep 30, 2026.

    Next Earnings DateNov 18, 2026 (expected)
    Last Earnings DateAug 14, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 58.28% in the quarter ended Jun 30, 2026 and grew 401.31% a year over 2 years.

    Shares Outstanding40.52M
    Shares Change (YoY)+1156.05%
    Shares Change (QoQ)+58.28%
    Share Count Growth (2Y CAGR)+401.31%

    Valuation Ratios

    Sales and book value multiples are 5.2x and 0.6x. Its year-end P/S ranged from 0.2x to 80.6x from 2018 to 2025.

    P/S Ratio5.2x
    P/B Ratio0.6x

    Valuation history and multiples

    Price Statistics

    The stock is down 66.45% over 52 weeks and trades 26.47% below its 50-day average.

    Beta (1Y)2.26
    52-Week Change-66.45%
    1-Month Change-26.84%
    3-Month Change-53.59%
    6-Month Change-30.14%
    5-Year Change-99.81%
    10-Year Change-99.36%
    Total Return (1Y)-66.45%
    Total Return (3Y CAGR)-51.81%
    Total Return (5Y CAGR)-72.09%
    Max Drawdown (1Y)-94.07%
    Max Drawdown (3Y)-94.07%
    Sharpe Ratio (1Y)-0.37
    Correlation with SPY (1Y)0.10
    50-Day Average$0.68
    200-Day Average$0.79
    52-Week Range$0.45 to $8.10
    RSI (14 Days)35.3
    Average Volume (20 Days)122.14K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.26x current liabilities, and total debt is 0.10x shareholder equity.

    Current Ratio0.26x
    Quick Ratio0.08x
    Debt / Equity0.10x
    Interest Coverage-44.20x

    Returns and Efficiency

    Return on invested capital is -8.69% over the last 12 months, against a 5-year average of -20.23%.

    Return on Equity (ROE)-12.37%
    Return on Assets (ROA)-10.01%
    Return on Invested Capital (ROIC)-8.69%
    Return on Capital Employed (ROCE)-11.82%
    ROE (5Y Average)-53.11%
    ROA (5Y Average)-19.63%
    ROIC (5Y Average)-20.23%
    Asset Turnover0.13x
    Inventory Turnover2.41x
    Receivables Turnover15.47x
    Cash Conversion Cycle-184 days

    Scores

    CPHI has an Altman Z-Score of -0.52, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score-0.52
    Altman Z ZoneDistress
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $3.91M over the last 12 months is down 10.97% from the 12 months before.

    Revenue$3.91M
    Revenue Growth (YoY)-10.97%
    Gross Profit$462.21K
    Operating Income-$4.38M
    Pretax Income-$4.47M
    Net Income-$4.47M
    EBITDA-$1.37M
    EBIT-$4.38M

    Trailing 12 months through Jun 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 80.92% of the $44.71M in total assets.

    Cash and Equivalents$304.87K
    Total Debt$3.60M
    Net Debt$3.30M
    Net Debt Per Share$0.08
    Working Capital-$5.67M
    Shareholder Equity$36.18M
    Book Value Per Share$0.89
    Tangible Book Value-$2.16M
    Total Assets$44.71M
    Total Liabilities$8.53M

    Balance sheet as of Jun 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$173.12K
    FCF Per Share$0.00
    Depreciation and Amortization$3.01M

    Trailing 12 months through Jun 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -111.84%, against a 5-year average of -58.44%.

    Gross Margin11.81%
    Operating Margin-111.84%
    Pretax Margin-114.33%
    Net Margin-114.33%
    EBITDA Margin-34.90%
    EBIT Margin-111.84%
    Gross Margin (5Y Average)-10.17%
    Operating Margin (5Y Average)-58.44%
    Net Margin (5Y Average)-61.94%

    Growth

    Revenue fell 20.03% a year over 3 years.

    Revenue Growth (3Y CAGR)-20.03%
    Revenue Growth (5Y CAGR)-17.53%

    Revenue and profit by year

    Stock Splits

    The last split was a 1-for-10 reverse split on Apr 15, 2025.

    Last Split DateApr 15, 2025
    Split TypeReverse split
    Split Ratio1:10

    Peer Position

    Against 5 similar companies, CPHI has the 2nd highest P/S.

    P/S Ratio5.2x vs 1.8x median
    ROIC-8.69% vs -18.01% median
    Revenue Growth (Trailing 4 Quarters, YoY)-10.97% vs +10.71% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About CPHI

    What is CPHI's market cap?

    China Pharma Holdings has a market cap of $22.29M. Its enterprise value, which adds debt and subtracts cash, is $25.59M.

    How many shares of CPHI are outstanding?

    China Pharma Holdings has 40.52M shares outstanding. The count is up 1156.05% from a year earlier.

    Does CPHI pay a dividend?

    No. China Pharma Holdings does not pay a dividend.

    How much debt does CPHI have?

    China Pharma Holdings has $3.60M of total debt and $304.87K of cash and equivalents, a net debt position of $3.30M.